Latest Institutional Transactions on Adagio Therapeutics, Inc. (ADGI)
This table provides information on the latest institutional transactions involving Adagio Therapeutics, Inc. (ADGI) stock. The table includes the name of the institution, the type of operation (buy or sell), whether options were involved, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the transaction has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2022
Q4 2021
|
Triatomic Management LP
New York, NY |
BUY
|
- |
25.8KNew |
$164K - $1.21M
|
25.8K
$85.4K
|
|
Feb 14, 2022
Q4 2021
|
Antipodean Advisors LLC
New York, NY |
SELL
|
- |
-190KClosed |
$1.21M - $8.94M
|
0
$0
|
|
Feb 11, 2022
Q4 2021
|
Eam Investors, LLC
Solana Beach, CA |
SELL
|
- |
-29.3KClosed |
$186K - $1.38M
|
0
$0
|
|
Feb 11, 2022
Q4 2021
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-113KClosed |
$719K - $5.32M
|
0
$0
|
|
Feb 10, 2022
Q4 2021
|
Td Asset Management Inc
|
BUY
|
- |
31.3KNew |
$199K - $1.47M
|
31.3K
$104K
|
|
Feb 10, 2022
Q4 2021
|
Rathbones Group PLC
Liverpool, X0 |
BUY
|
- |
10KNew |
$63.5K - $470K
|
10K
$33.1K
|
|
Feb 07, 2022
Q4 2021
|
M&T Bank Corp
|
SELL
|
- |
-10.3KClosed |
$65.5K - $485K
|
0
$0
|
|
Feb 07, 2022
Q4 2021
|
Inverness Counsel LLC
|
SELL
|
- |
-12KClosed |
$76.2K - $564K
|
0
$0
|
|
Jan 18, 2022
Q4 2021
|
Lindbrook Capital, LLC
|
SELL
|
- |
-800Closed |
$5.08K - $37.6K
|
0
$0
|
|
Jan 12, 2022
Q4 2021
|
Ifp Advisors, Inc
|
SELL
|
- |
-100Closed |
$635 - $4.7K
|
0
$0
|
|
Q3 2021 | |||||||
May 17, 2024
Q3 2021
|
Met Life Investment Management, LLC
Whippany, NJ |
BUY
|
- |
7.74KNew |
$162K - $434K
|
7.74K
$25.6K
|
|
Jun 21, 2023
Q3 2021
|
Metropolitan Life Insurance CO
New York, NY |
BUY
|
- |
5.86KNew |
$122K - $328K
|
5.86K
$19.4K
|
|
Mar 22, 2023
Q3 2021
|
American Portfolios Advisors
Holbrook, NY |
BUY
|
- |
560New |
$11.7K - $31.4K
|
560
$1.85K
|
|
Nov 14, 2022
Q3 2021
|
Norges Bank
Oslo, Q8 |
BUY
|
- |
10.7KNew |
$223K - $599K
|
10.7K
$35.4K
|